Actionnariat et activité des initiés pour Agenus Inc. (AGEN): transactions des initiés, déclarations de trading du Sénat et de la Chambre américaine et actions en circulation. Suivez comment dirigeants et politiciens négocient le titre.
Prix
| Prix | $7.21 |
| Capitalisation | $300M |
| Bourse | NASDAQ |
| Pays | US |
Transactions d'Initiés Récentes
| Date | Initié | Type | Actions | Valeur |
|---|---|---|---|---|
| 2026-08-10 | ARMEN GARO H | A-Award | 1,971,500 | $15.3M |
| 2026-08-05 | HARRISON THOMAS L | A-Award | 50,000 | $389K |
| 2026-08-05 | Corvese Brian | A-Award | 100,000 | $778K |
| 2026-08-05 | Wright Timothy | A-Award | 50,000 | $389K |
| 2026-08-05 | O'Day Steven J | A-Award | 100,000 | $778K |
| 2026-08-05 | Hirsch Susan B | A-Award | 50,000 | $389K |
| 2026-08-05 | Buell Jennifer | A-Award | 200,000 | $1.6M |
| 2026-07-10 | ARMEN GARO H | A-Award | 4,852 | $16K |
| 2026-07-01 | HARRISON THOMAS L | A-Award | 8,547 | $31K |
| 2026-07-01 | Wright Timothy | A-Award | 2,267 |
Bilan (10 ans)
| Année | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Trésorerie | $76.4M | $60.2M | $53.1M | $61.8M | $99.9M | $291.9M | $178.7M | $76.1M | $40.4M | $3.0M |
| Placements à Court Terme | 0 | 0 | 0 | 0 | 0 | $15.0M | $14.7M | 0 | 0 | 0 |
| Créances | $11.4M | $1.1M | $938141 | $16.3M | $1.2M | $1.5M | $2.7M | $25.8M | $407000 | $1.8M |
| Stocks | $88200 | $79491 | $55491 | $7.4M | 0 | $20.4M | $13.8M | 0 | 0 | 0 |
| Actifs Courants | $91.3M | $73.6M | $74.8M | $86.5M | $113.8M | $332.0M | $213.1M | $112.4M | $45.6M | $133.4M |
| Immobilisations Corporelles | $25.6M | $26.2M | $25.1M | $33.7M | $60.3M | $91.1M | $164.3M | $163.0M | $147.4M | $24.2M |
| Goodwill | $22.4M | $23.0M | $22.9M | $23.2M | $25.5M | $24.9M | $25.5M | $24.7M | $24.1M | $24.1M |
| Actifs Incorporels | $16.4M | $31.8M | $12.3M | $10.5M | $10.9M | $8.5M | $6.2M | $4.4M | $3.4M | $3.0M |
| Actifs Totaux | $157.0M | $138.4M | $136.4M | $155.3M | $214.5M | $466.0M | $413.6M | $313.9M | $226.3M | $226.8M |
| Dettes Fournisseurs | $5.4M | $8.1M | $13.6M | $13.6M | $17.0M | $30.5M | $40.9M | $61.4M | $61.5M | $83.0M |
| Dette à Court Terme | $146061 | $20.6M | $146000 | $646000 | $833000 | $728000 | $575000 | $146000 | $2.7M | $155.1M |
| Passifs Courants | $40.9M | $56.4M | $68.1M | $122.2M | $129.9M | $156.9M | $189.0M | $255.9M | $221.4M | $323.5M |
| Dette à Long Terme | $130.5M | $142.4M | $13.21B | $13.4M | $18.9M | $12.8M | $12.6M | $12.8M | $30.5M | $169.7M |
| Passifs Totaux | $196.1M | $214.2M | $310.9M | $386.7M | $426.0M | $418.0M | $468.5M | $462.3M | $532.7M | $504.7M |
| Réserves | -$905.3M | -$1.03B | -$1.18B | -$1.28B | -$1.47B | -$1.49B | -$1.71B | -$1.96B | -$2.18B | -$2.18B |
| Capitaux Propres | -$39.1M | -$75.8M | -$172.5M | -$225.4M | -$203.7M | $34.4M | -$61.3M | -$160.3M | -$326.4M | -$271.1M |
| Dette Totale | $130.7M | $163.0M | $13.4M | $23.4M | $55.7M | $58.3M | $78.4M | $93.2M | $94.9M | $334.9M |
| Dette Nette | $54.3M | $102.8M | -$39.7M | -$38.4M | -$44.1M | -$248.6M | -$114.9M | $17.1M | $54.4M | $331.9M |
| Fonds de Roulement | $50.5M | $17.1M | $6.7M | -$35.7M | -$16.1M | $175.0M | $24.2M | -$143.5M | -$175.8M | -$190.1M |
Santé financière
| Dette / Capitaux propres | -0.20 |
| Ratio de liquidité | 0.34 |
Rentabilité
| Rentabilité des capitaux propres | -38.12% |
| Rentabilité du capital investi | -129.48% |
| Rentabilité des actifs | 53.28% |
| Marge brute | 75.63% |
| Marge opérationnelle | 27.28% |
| Marge nette | 69.34% |
Entreprises liées: ABOS · FATE · HURA · INO · IRD · PLRX · SEER
Explorer le secteur: Healthcare · Biotechnology
Plus de sections de AGEN: Vue d'ensemble · Financiers · Valorisation · Statistiques · Estimations · Technique · Actualités · Événements
Découvrir plus: Radar — signaux d'actions sous-évaluées · Académie d'Investissement — apprenez à analyser les actions